201 results
8-K
EX-99.1
INVA
Innoviva Inc
8 May 24
Innoviva Reports First Quarter 2024 Financial Results; Highlights Recent Company Progress
4:44pm
, general and administrative
Research and development
Amortization of acquired intangible assets
Changes in fair values of equity method investments, net … 3 zoliflodacin clinical trial results highlighted in an oral presentation given by the Company’s non-profit partner, The Global Antibiotic Research
8-K
EX-99.1
2tda wxcqs
29 Feb 24
Innoviva Reports Fourth Quarter and Full Year 2023 Financial Results; Highlights Recent Company Progress
4:15pm
8-K
EX-99.1
qg3206
1 Nov 23
Innoviva Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
4:30pm
8-K
EX-10.1
8hsl0j jdmj8wk1t
25 Aug 23
Innoviva Appoints Stephen Basso as Chief Financial Officer
5:24pm
8-K
EX-99.1
kwum9488z5 41xjjojbx
2 Aug 23
Innoviva Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress
4:15pm
8-K
EX-99.1
ptwa2f9zi8 qo
24 May 23
Corporate Presentation May 2023
5:18pm
8-K
EX-99.1
v4geijz
9 May 23
Innoviva Reports First Quarter 2023 Financial Results and Highlights Recent
5:21pm
8-K
EX-99.1
mrwn3dhkupf6jg
9 Nov 22
Innoviva Reports Third Quarter 2022 Financial Results and Highlights Recent Company Progress
4:17pm
8-K/A
EX-99.1
tg1jydbfmfjcaw1axozp
28 Oct 22
Completion of Acquisition or Disposition of Assets
4:22pm
8-K
EX-99.1
uqwr5lqe6 3pd
23 Aug 22
Other Events
4:08pm
8-K
EX-99.1
pj5a5tl3ju4xgep2ff9
27 Jul 22
Innoviva Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress
4:16pm